U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies

Abstract Aims Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infe...

Full description

Saved in:
Bibliographic Details
Published inEuropean heart journal Vol. 39; no. 14; pp. 1181 - 1190
Main Authors Madsen, Christian M, Varbo, Anette, Tybjærg-Hansen, Anne, Frikke-Schmidt, Ruth, Nordestgaard, Børge G
Format Journal Article
LanguageEnglish
Published England Oxford University Press 07.04.2018
Subjects
Online AccessGet full text
ISSN0195-668X
1522-9645
1522-9645
DOI10.1093/eurheartj/ehx665

Cover

Abstract Abstract Aims Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population. Methods and results We included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003–13 or 1991–94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31–2.34) and 1.43 (1.16–1.76), compared to those with HDL cholesterol of 2.2–2.3 mmol/L (85–95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16–3.43) and 1.13 (0.80–1.60). Conclusion Low and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality.
AbstractList Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population.AimsPreclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population.We included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003-13 or 1991-94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31-2.34) and 1.43 (1.16-1.76), compared to those with HDL cholesterol of 2.2-2.3 mmol/L (85-95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16-3.43) and 1.13 (0.80-1.60).Methods and resultsWe included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003-13 or 1991-94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31-2.34) and 1.43 (1.16-1.76), compared to those with HDL cholesterol of 2.2-2.3 mmol/L (85-95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16-3.43) and 1.13 (0.80-1.60).Low and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality.ConclusionLow and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality.
Abstract Aims Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population. Methods and results We included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003–13 or 1991–94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31–2.34) and 1.43 (1.16–1.76), compared to those with HDL cholesterol of 2.2–2.3 mmol/L (85–95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16–3.43) and 1.13 (0.80–1.60). Conclusion Low and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality.
Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population. We included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003-13 or 1991-94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31-2.34) and 1.43 (1.16-1.76), compared to those with HDL cholesterol of 2.2-2.3 mmol/L (85-95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16-3.43) and 1.13 (0.80-1.60). Low and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality.
Author Tybjærg-Hansen, Anne
Nordestgaard, Børge G
Frikke-Schmidt, Ruth
Varbo, Anette
Madsen, Christian M
Author_xml – sequence: 1
  givenname: Christian M
  surname: Madsen
  fullname: Madsen, Christian M
  organization: Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark
– sequence: 2
  givenname: Anette
  surname: Varbo
  fullname: Varbo, Anette
  organization: Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark
– sequence: 3
  givenname: Anne
  surname: Tybjærg-Hansen
  fullname: Tybjærg-Hansen, Anne
  organization: The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark
– sequence: 4
  givenname: Ruth
  surname: Frikke-Schmidt
  fullname: Frikke-Schmidt, Ruth
  organization: The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark
– sequence: 5
  givenname: Børge G
  surname: Nordestgaard
  fullname: Nordestgaard, Børge G
  email: boerge.nordestgaard@regionh.dk
  organization: Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29228167$$D View this record in MEDLINE/PubMed
BookMark eNqFkTlPxDAQhS0EguXoqZBLJBSwnWSc0KHllFaiYSW6yOtMFEM2DrbD8e_JkoWCAirLnu_NPM_bJZutbZGQQ85OOcvjM-xdjcqFpzOs3wHSDTLhqRBRDkm6SSaM52kEkD3ukF3vnxhjGXDYJjsiFyLjICekmUe-Vh2W1GGjgrGtr01HbUVvL2dUtcO78c-ru2kr1APQe1oaj8rjOQ1vlnbO-m5VeUXa2a4fu0SLASiptrV1gfrQlwb9PtmqVOPxYH3ukfn11cP0Nprd39xNL2aRThgPUR4zFeuMcUh0JbioFihRykzpUidZqkAAq2QSl1hBqnkmRQYgF1KUaSwkyHiPHI99B28vPfpQLI3X2DSqxcF_wXMJjIk4WaFHa7RfLLEsOmeWyn0U3xsaADYCevind1j9IJwVqxCKnxCKMYRBAr8k2oSvrQSnTPOX8GQU2r77f8wn4JCg9g
CitedBy_id crossref_primary_10_3389_fphar_2021_720283
crossref_primary_10_1097_MOL_0000000000000589
crossref_primary_10_1186_s13045_020_00963_6
crossref_primary_10_3389_fneur_2022_891622
crossref_primary_10_1024_1661_8157_a003241
crossref_primary_10_1186_s12944_022_01638_6
crossref_primary_10_3389_fcvm_2020_00039
crossref_primary_10_51789_cmsj_2021_1_e13
crossref_primary_10_1016_j_lanwpc_2023_100874
crossref_primary_10_1093_eurheartj_ehz962
crossref_primary_10_1007_s11657_019_0579_0
crossref_primary_10_1016_j_jacl_2021_10_005
crossref_primary_10_1002_jmv_29794
crossref_primary_10_1007_s15027_017_1275_x
crossref_primary_10_3389_fnut_2024_1430835
crossref_primary_10_1161_ATVBAHA_120_314050
crossref_primary_10_1124_jpet_119_261719
crossref_primary_10_1016_j_gastha_2021_12_009
crossref_primary_10_1016_j_numecd_2021_06_016
crossref_primary_10_1186_s13054_023_04589_1
crossref_primary_10_1002_jmv_70207
crossref_primary_10_1097_MOL_0000000000000612
crossref_primary_10_1016_j_athplu_2025_02_001
crossref_primary_10_1097_MOL_0000000000000577
crossref_primary_10_1016_j_pmedr_2021_101461
crossref_primary_10_1161_ATVBAHA_120_315669
crossref_primary_10_1253_circj_CJ_20_0348
crossref_primary_10_1016_j_numecd_2022_10_001
crossref_primary_10_1016_j_plipres_2021_101092
crossref_primary_10_3343_alm_2022_42_4_415
crossref_primary_10_1016_j_jacc_2022_10_019
crossref_primary_10_1016_j_pathol_2018_09_062
crossref_primary_10_1161_CIRCULATIONAHA_120_050808
crossref_primary_10_3390_jcm10245955
crossref_primary_10_1186_s12879_024_10125_5
crossref_primary_10_1016_j_ebiom_2024_104981
crossref_primary_10_1093_jalm_jfaa002
crossref_primary_10_14309_ajg_0000000000002179
crossref_primary_10_1161_ATVBAHA_120_314983
crossref_primary_10_1016_j_ijcard_2018_11_095
crossref_primary_10_1080_07853890_2024_2400312
crossref_primary_10_29058_mjwbs_1432328
crossref_primary_10_1016_j_cjca_2019_03_016
crossref_primary_10_1097_MOL_0000000000000563
crossref_primary_10_1186_s12985_022_01865_4
crossref_primary_10_1093_cvr_cvac194
crossref_primary_10_1093_cvr_cvad043
crossref_primary_10_1017_S0007114519001429
crossref_primary_10_61186_aassjournal_1300
crossref_primary_10_1371_journal_pgen_1009713
crossref_primary_10_1371_journal_pone_0210808
crossref_primary_10_1136_bjo_2024_326062
crossref_primary_10_1161_CIRCULATIONAHA_120_048568
crossref_primary_10_1016_j_addr_2020_10_006
crossref_primary_10_1097_MD_0000000000036288
crossref_primary_10_2139_ssrn_4074563
crossref_primary_10_1093_cvr_cvy198
crossref_primary_10_1093_eurheartj_ehy187
crossref_primary_10_31612_2616_4868_6_2024_17
crossref_primary_10_1016_j_cca_2020_07_015
crossref_primary_10_1016_j_beem_2022_101689
crossref_primary_10_1053_j_jrn_2020_09_002
crossref_primary_10_3389_fcvm_2022_989428
crossref_primary_10_1016_j_bbalip_2021_159063
crossref_primary_10_1002_ijc_34164
crossref_primary_10_1016_j_amjcard_2021_11_041
crossref_primary_10_1111_imm_13348
crossref_primary_10_1016_j_arteri_2021_11_006
crossref_primary_10_1007_s10096_019_03543_w
crossref_primary_10_1016_j_ebiom_2022_104166
crossref_primary_10_1038_s41598_025_90766_x
crossref_primary_10_1186_s12944_020_01382_9
crossref_primary_10_1016_j_bbalip_2021_159058
crossref_primary_10_1161_ATVBAHA_119_313381
crossref_primary_10_1016_j_atherosclerosis_2018_06_881
crossref_primary_10_1093_cvr_cvab164
crossref_primary_10_20945_2359_3997000000585
crossref_primary_10_1164_rccm_201806_1157OC
crossref_primary_10_1097_MOL_0000000000000705
crossref_primary_10_1016_j_beem_2023_101751
crossref_primary_10_1186_s12986_020_00455_x
crossref_primary_10_3746_pnf_2023_28_3_263
crossref_primary_10_52727_2078_256X_2022_18_2_117_128
crossref_primary_10_32604_biocell_2023_031063
crossref_primary_10_1016_j_rec_2022_10_001
crossref_primary_10_1016_j_jlr_2024_100728
crossref_primary_10_1016_S2213_8587_19_30264_5
crossref_primary_10_1186_s12902_024_01758_3
crossref_primary_10_1007_s42000_018_0058_9
crossref_primary_10_7554_eLife_75170
crossref_primary_10_3390_ijms23158128
crossref_primary_10_1016_j_atherosclerosis_2021_12_009
crossref_primary_10_1016_j_bbadis_2025_167761
crossref_primary_10_1097_MOL_0000000000000899
crossref_primary_10_3892_etm_2023_12350
crossref_primary_10_51789_cmsj_2022_2_e5
crossref_primary_10_1002_iid3_861
crossref_primary_10_1080_10409238_2021_1925217
crossref_primary_10_1016_j_athplu_2023_01_002
crossref_primary_10_1038_s41598_020_71921_y
crossref_primary_10_3390_ijms21030739
crossref_primary_10_1186_s12889_025_22251_z
crossref_primary_10_15420_usc_2019_3_2
crossref_primary_10_5551_jat_63894
crossref_primary_10_1016_j_amjmed_2020_07_022
crossref_primary_10_3390_nu10060764
crossref_primary_10_1161_ATVBAHA_119_313651
crossref_primary_10_1373_clinchem_2018_299636
crossref_primary_10_1186_s12933_024_02447_0
crossref_primary_10_5551_jat_47183
crossref_primary_10_1016_j_tem_2020_01_003
crossref_primary_10_1097_MOL_0000000000000642
crossref_primary_10_1161_ATVBAHA_118_310727
crossref_primary_10_1093_eurheartj_ehac605
crossref_primary_10_1161_STROKEAHA_121_034393
crossref_primary_10_1093_eurheartj_ehz502
crossref_primary_10_1111_cts_13462
crossref_primary_10_1097_CCM_0000000000004519
crossref_primary_10_3390_ijms23179777
crossref_primary_10_2174_0929867326666190201142321
crossref_primary_10_3390_ijms22094547
crossref_primary_10_1002_hep4_1745
crossref_primary_10_1016_j_artere_2022_05_002
crossref_primary_10_1210_clinem_dgab095
crossref_primary_10_3390_cells10051041
crossref_primary_10_3390_cells10051061
crossref_primary_10_1111_imm_13260
crossref_primary_10_1093_cvr_cvz127
crossref_primary_10_1016_j_jlr_2021_100067
crossref_primary_10_3389_fmed_2024_1333472
crossref_primary_10_1016_j_jlr_2021_100061
crossref_primary_10_1038_s41598_019_57373_z
crossref_primary_10_1093_eurheartj_ehx734
crossref_primary_10_3390_biomedicines10092320
crossref_primary_10_1016_j_recesp_2022_08_004
crossref_primary_10_1186_s12937_024_00983_9
crossref_primary_10_1007_s11883_020_00902_3
crossref_primary_10_3390_jcm13237242
crossref_primary_10_1016_j_ijbiomac_2023_124342
crossref_primary_10_1177_2047487319848214
Cites_doi 10.1093/eurheartj/ehx274
10.2337/db14-1603
10.1016/j.jacc.2012.08.1026
10.1136/bmj.g4379
10.1093/eurheartj/ehx163
10.1161/01.CIR.101.16.1907
10.1084/jem.180.3.1025
10.1097/01.CCM.0000171183.79525.6B
10.1159/000347077
10.1016/j.jcrc.2014.04.018
10.1093/eurheartj/ehw272
10.1038/nature14462
10.1054/clnu.2002.0575
10.1007/s00125-006-0570-3
10.1038/nature01461
10.1001/jama.299.21.2524
10.1016/j.atherosclerosis.2012.07.029
10.1093/eurheartj/ehw152
10.1056/NEJMoa0706628
10.1074/jbc.M112.442699
10.1161/CIRCRESAHA.115.306249
10.1161/ATVBAHA.106.136325
10.2307/30141957
10.1016/S0735-1097(03)00407-8
10.1093/cvr/cvu150
10.1126/science.1189731
10.1111/j.1365-2362.2010.02269.x
10.1126/science.aad3517
10.1007/s00392-007-0611-z
ContentType Journal Article
Copyright Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: journals.permissions@oup.com. 2017
Copyright_xml – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: journals.permissions@oup.com. 2017
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1093/eurheartj/ehx665
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Focus Issue on Lipids
EISSN 1522-9645
EndPage 1190
ExternalDocumentID 29228167
10_1093_eurheartj_ehx665
10.1093/eurheartj/ehx665
Genre Journal Article
GroupedDBID ---
-E4
.2P
.I3
.XZ
.ZR
08P
0R~
18M
1TH
29G
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAJKP
AAJQQ
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
ABEUO
ABIXL
ABKDP
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCGUY
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M41
M49
MHKGH
ML0
N9A
NGC
NOMLY
NOYVH
NU-
O9-
OAUYM
OAWHX
OB3
OCZFY
ODMLO
OGROG
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
ROZ
RUSNO
RW1
RXO
SEL
TCURE
TEORI
TJX
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
AAFWJ
AAYXX
ABDFA
ABEJV
ABGNP
ABJNI
ABPQP
ABVGC
ADGHP
ADNBA
AEMQT
AFYAG
AGORE
AHMMS
AJBYB
AJNCP
ALXQX
CITATION
JXSIZ
NPM
7X8
ID FETCH-LOGICAL-c401t-930a3c80164cf212fbe7e778acdc485a6260f743def65c18728667b72d5327673
ISSN 0195-668X
1522-9645
IngestDate Thu Jul 10 23:25:18 EDT 2025
Wed Feb 19 02:44:10 EST 2025
Tue Jul 01 01:29:35 EDT 2025
Thu Apr 24 23:07:59 EDT 2025
Wed Sep 11 04:48:09 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 14
Keywords HDL
Infectious disease
Lipids
General population
Lipoproteins
Epidemiology
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)
http://academic.oup.com/journals/pages/about_us/legal/notices
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c401t-930a3c80164cf212fbe7e778acdc485a6260f743def65c18728667b72d5327673
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 29228167
PQID 1976002347
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1976002347
pubmed_primary_29228167
crossref_primary_10_1093_eurheartj_ehx665
crossref_citationtrail_10_1093_eurheartj_ehx665
oup_primary_10_1093_eurheartj_ehx665
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-04-07
PublicationDateYYYYMMDD 2018-04-07
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-07
  day: 07
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle European heart journal
PublicationTitleAlternate Eur Heart J
PublicationYear 2018
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Barter ( key 20180407055350_ehx665-B25) 2007; 357
Madsen ( key 20180407055350_ehx665-B18) 2017; 38
Wurfel ( key 20180407055350_ehx665-B20) 1994; 180
Guo ( key 20180407055350_ehx665-B6) 2013; 288
Catapano ( key 20180407055350_ehx665-B9) 2014; 103
Wang ( key 20180407055350_ehx665-B12) 2012; 225
Rodriguez-Sanz ( key 20180407055350_ehx665-B15) 2013; 35
Lekkou ( key 20180407055350_ehx665-B4) 2014; 29
Frikke-Schmidt ( key 20180407055350_ehx665-B1) 2008; 299
Chien ( key 20180407055350_ehx665-B5) 2005; 33
Vanhamme ( key 20180407055350_ehx665-B8) 2003; 422
Grion ( key 20180407055350_ehx665-B16) 2010; 40
Nordestgaard ( key 20180407055350_ehx665-B19) 2016; 37
Barter ( key 20180407055350_ehx665-B23) 2017; 38
Zanoni ( key 20180407055350_ehx665-B22) 2016; 351
Agerholm-Larsen ( key 20180407055350_ehx665-B24) 2000; 101
Yvan-Charvet ( key 20180407055350_ehx665-B11) 2010; 328
Shor ( key 20180407055350_ehx665-B13) 2008; 97
Benfield ( key 20180407055350_ehx665-B29) 2007; 50
Birjmohun ( key 20180407055350_ehx665-B7) 2007; 27
Keene ( key 20180407055350_ehx665-B3) 2014; 349
Haase ( key 20180407055350_ehx665-B28) 2015; 64
Blaho ( key 20180407055350_ehx665-B10) 2015; 523
Delgado-Rodríguez ( key 20180407055350_ehx665-B14) 1997; 18
Catapano ( key 20180407055350_ehx665-B26) 2016; 37
Nordestgaard ( key 20180407055350_ehx665-B27) 2016; 118
Canturk ( key 20180407055350_ehx665-B17) 2002; 21
Andersen ( key 20180407055350_ehx665-B21) 2003; 41
Varbo ( key 20180407055350_ehx665-B2) 2013; 61
References_xml – volume: 38
  start-page: 2487
  year: 2017
  ident: key 20180407055350_ehx665-B23
  article-title: HDL cholesterol concentration or HDL function: which matters?
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehx274
– volume: 64
  start-page: 3328
  year: 2015
  ident: key 20180407055350_ehx665-B28
  article-title: HDL cholesterol and risk of type 2 diabetes: a Mendelian randomization study
  publication-title: Diabetes
  doi: 10.2337/db14-1603
– volume: 61
  start-page: 427
  year: 2013
  ident: key 20180407055350_ehx665-B2
  article-title: Remnant cholesterol as a causal risk factor for ischemic heart disease
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.08.1026
– volume: 349
  start-page: g4379.
  year: 2014
  ident: key 20180407055350_ehx665-B3
  article-title: Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
  publication-title: BMJ
  doi: 10.1136/bmj.g4379
– volume: 38
  start-page: 2478
  year: 2017
  ident: key 20180407055350_ehx665-B18
  article-title: Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehx163
– volume: 101
  start-page: 1907
  year: 2000
  ident: key 20180407055350_ehx665-B24
  article-title: Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.16.1907
– volume: 180
  start-page: 1025
  year: 1994
  ident: key 20180407055350_ehx665-B20
  article-title: Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS
  publication-title: J Exp Med
  doi: 10.1084/jem.180.3.1025
– volume: 33
  start-page: 1688
  year: 2005
  ident: key 20180407055350_ehx665-B5
  article-title: Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis
  publication-title: Crit Care Med
  doi: 10.1097/01.CCM.0000171183.79525.6B
– volume: 35
  start-page: 291
  year: 2013
  ident: key 20180407055350_ehx665-B15
  article-title: High-density lipoprotein: a novel marker for risk of in-hospital infection in acute ischemic stroke patients?
  publication-title: Cerebrovasc Dis
  doi: 10.1159/000347077
– volume: 29
  start-page: 723
  year: 2014
  ident: key 20180407055350_ehx665-B4
  article-title: Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis
  publication-title: J Crit Care
  doi: 10.1016/j.jcrc.2014.04.018
– volume: 37
  start-page: 2999
  year: 2016
  ident: key 20180407055350_ehx665-B26
  article-title: 2016 ESC/EAS Guidelines for the management of dyslipidaemias
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehw272
– volume: 523
  start-page: 342
  year: 2015
  ident: key 20180407055350_ehx665-B10
  article-title: HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation
  publication-title: Nature
  doi: 10.1038/nature14462
– volume: 21
  start-page: 431
  year: 2002
  ident: key 20180407055350_ehx665-B17
  article-title: Risk of nosocomial infections and effects of total cholesterol, HDL cholesterol in surgical patients
  publication-title: Clin Nutr
  doi: 10.1054/clnu.2002.0575
– volume: 50
  start-page: 549
  year: 2007
  ident: key 20180407055350_ehx665-B29
  article-title: Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome
  publication-title: Diabetologia
  doi: 10.1007/s00125-006-0570-3
– volume: 422
  start-page: 83
  year: 2003
  ident: key 20180407055350_ehx665-B8
  article-title: Apolipoprotein L-I is the trypanosome lytic factor of human serum
  publication-title: Nature
  doi: 10.1038/nature01461
– volume: 299
  start-page: 2524
  year: 2008
  ident: key 20180407055350_ehx665-B1
  article-title: Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease
  publication-title: JAMA
  doi: 10.1001/jama.299.21.2524
– volume: 225
  start-page: 105
  year: 2012
  ident: key 20180407055350_ehx665-B12
  article-title: HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2012.07.029
– volume: 37
  start-page: 1944
  year: 2016
  ident: key 20180407055350_ehx665-B19
  article-title: Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehw152
– volume: 357
  start-page: 2109
  year: 2007
  ident: key 20180407055350_ehx665-B25
  article-title: Effects of torcetrapib in patients at high risk for coronary events
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0706628
– volume: 288
  start-page: 17947
  year: 2013
  ident: key 20180407055350_ehx665-B6
  article-title: High density lipoprotein protects against polymicrobe-induced sepsis in mice
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.442699
– volume: 118
  start-page: 547
  year: 2016
  ident: key 20180407055350_ehx665-B27
  article-title: Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.115.306249
– volume: 27
  start-page: 1153
  year: 2007
  ident: key 20180407055350_ehx665-B7
  article-title: High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.106.136325
– volume: 18
  start-page: 9
  year: 1997
  ident: key 20180407055350_ehx665-B14
  article-title: Total cholesterol, HDL-cholesterol, and risk of nosocomial infection: a prospective study in surgical patients. Infect
  publication-title: Control Hosp Epidemiol
  doi: 10.2307/30141957
– volume: 41
  start-page: 1972
  year: 2003
  ident: key 20180407055350_ehx665-B21
  article-title: Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(03)00407-8
– volume: 103
  start-page: 372
  year: 2014
  ident: key 20180407055350_ehx665-B9
  article-title: HDL in innate and adaptive immunity
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvu150
– volume: 328
  start-page: 1689
  year: 2010
  ident: key 20180407055350_ehx665-B11
  article-title: ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation
  publication-title: Science
  doi: 10.1126/science.1189731
– volume: 40
  start-page: 330
  year: 2010
  ident: key 20180407055350_ehx665-B16
  article-title: Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients
  publication-title: Eur J Clin Invest
  doi: 10.1111/j.1365-2362.2010.02269.x
– volume: 351
  start-page: 1166
  year: 2016
  ident: key 20180407055350_ehx665-B22
  article-title: Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
  publication-title: Science
  doi: 10.1126/science.aad3517
– volume: 97
  start-page: 227
  year: 2008
  ident: key 20180407055350_ehx665-B13
  article-title: Low HDL levels and the risk of death, sepsis and malignancy
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-007-0611-z
SSID ssj0008616
Score 2.5937912
Snippet Abstract Aims Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL...
Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune...
SourceID proquest
pubmed
crossref
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1181
Title U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies
URI https://www.ncbi.nlm.nih.gov/pubmed/29228167
https://www.proquest.com/docview/1976002347
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zj9MwELbKIiFeEDflkpH2Ba1MN3ESO7ytgFU5lhe2aN8ix3boXmmVbcXxG_jRjM-my4IWXqI0Se3W82U8nvlmjNCmUoBaUZTERPlIJqkmHKYBIphOG85EUtiiPnsfi_Eke3eQHwwGP3uspeWifiF_XJhX8j9ShWsgV5Ml-w-SjY3CBTgH-cIRJAzHS8l4Qs6mYq6Vz0jx1Cvjmn_9YY04HihXy7MQkbF8jq8zw88KyZZb87iZFzGTm8l3m4J1bkvQBq7heSe-2RB7sdX_tda9rbxjx9UuMEokeng-i652uTVtpBkZ18H3-shG7YvuCxmL1jew067i_rvd4fGxJp_k9PRQ2cnD8PP7fouEW7qLm1u117WwDi4LV00yKGNX2SiALuupVpMhe6HOd_Ww9LKz__jInE-_FW4Hih4I5qcWBWmZpjwp2Gr-i6zEcOsKupoysMSMif32fZzXeZGEQDd0OYodjlx3pqy0b2DNxlnLm_xt-WLNmP2b6IZff-AdB6ZbaKDb2-janmdY3EEnAVO4jyk8azBgCgOmsMGU-bzCFPaYeokBUbiHKHweUdghCntE3UWT3Tf7r8bE78hBJKzDF6Sk24JKbsqyyQaMnqbWTDPGhVQy47kwq-MGbFKlmyKXCWcpvPisZqnKKQwpo_fQRjtr9QOEtZZpKjIplKRZzhpOqdoWEoZQZUrmYohGYQwr6cvVm11TTipHm6BVFEDlBDBEz-M35q5Uy1-e3QSxXOKxZ0FuFahdE0sTrYaBrZLSRrRpxobovhNobC3A4OEf7zxC11evxGO0seiW-gkYt4v6qcXcL0mirFM
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=U-shaped+relationship+of+HDL+and+risk+of+infectious+disease%3A+two+prospective+population-based+cohort+studies&rft.jtitle=European+heart+journal&rft.au=Madsen%2C+Christian+M&rft.au=Varbo%2C+Anette&rft.au=Tybj%C3%A6rg-Hansen%2C+Anne&rft.au=Frikke-Schmidt%2C+Ruth&rft.date=2018-04-07&rft.eissn=1522-9645&rft.volume=39&rft.issue=14&rft.spage=1181&rft_id=info:doi/10.1093%2Feurheartj%2Fehx665&rft_id=info%3Apmid%2F29228167&rft.externalDocID=29228167
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon